Phase IIi study of N4-behenoyl-l-beta-D-arabinofuranosylcytosine in adult acute leukemia-BH-AC-DMP therapy
Yamada, K.; Suzuki, H.; Kato, Y.
Nihon Ketsueki Gakkai Zasshi Journal of Japan Haematological Society 43(6): 1080-1085
1980
ISSN/ISBN: 0001-5806 PMID: 7331685 Document Number: 162635
Document emailed within 1 workday
Related Documents
Kimura, K. 1987: A phase Ii study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(8): 2475-2481Oh-ishi, J.; Kataoka, T.; Tsukagoshi, S.; Sakurai, Y.; Shibukawa, M.; Kobayashi, H. 1981: Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance Cancer Research 41(6): 2501-2506
Maehara, Y.; Kusumoto, T.; Sakaguchi, Y.; Kusumoto, H.; Anai, H.; Sugimachi, K. 1989: Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in Hela cells Anticancer Research 9(1): 41-44
Omura, G.A.; Vogler, W.R.; Smalley, R.V.; Maldonado, N.; Broun, G.O.; Knospe, W.H.; Ahn, Y.S.; Faguet, G.B. 1977: Phase Ii Study of beta-2'-deoxythioguanosine in adult acute leukemia Cancer Treatment Reports 61(7): 1379-1381
Toyoshima, S.; Fukuma, M.; Seto, Y.; Fujita, H.; Fukushima, K.; Tomioka, H.; Sakurai, T.; Sugimoto, Y.; Yagi, T.; Hoshino, T.; Sowa, T. 1981: In vivo distribution of 14C-labeled N4-behenoyl-1-beta-D-arabinofuranosylcytosine in mice Gan 72(1): 19-29
Oguro, M.; Takagi, T. 1982: Treatment of malignant lymphoma with single administration of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosylcytosine Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(3): 508-515
Caron, N.; Lee, S.H.; Kimball, A.P. 1977: Effects of 2'-deoxycoformycin, 9-beta-D-arabinofuranosyladenine 5'-phosphate, and 1-beta-D-arabinofuranosylcytosine triple combination therapy on intracerebral leukemia 1210 Cancer Research 37(9): 3274-3279
Taguchi, H.; Kubonishi, I.; Takehara, N.; Uemura, Y.; Iwahara, Y.; Eguchi, T.; Miyagi, T.; Sugito, S.; Muneishi, H.; Tanaka, Y. 1992: Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(9): 1309-1314
Omura, G.A. 1977: Combination therapy with 5-azacytidine plus beta-2'-deoxythioguanosine in adult acute leukemia Cancer Treatment Reports 61(5): 915-917
Spriggs, D.R.; Robbins, G.; Takvorian, T.; Kufe, D.W. 1985: Continuous infusion of high-dose 1-beta-D-arabinofuranosylcytosine: a phase i and pharmacological study Cancer Research 45(8): 3932-3936
Aglietta, M.; Colly, L. 1979: Relevance of recruitment-synchronization in the scheduling of 1-beta-D-arabinofuranosylcytosine in a slow-growing acute myeloid leukemia of the rat Cancer Research 39(7 Part 1): 2727-2732
TAnaka, M.; Yoshida, S. 1982: Altered sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate of DNA polymerase alpha from leukemic blasts of acute lymphoblastic leukemia Cancer Research 42(2): 649-653
Miyawaki, S.; Mizoguchi, H.; Tomonaga, M.; Kanamaru, A.; Tsukagoshi, S.; Nakamura, T.; Ohashi, Y.; Yoshida, S.; Ohno, R. 1998: A phase Ii study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(14): 2229-2242
Masaoka, T.; Ogawa, M.; Yamada, K.; Kimura, K.; Ohhashi, Y. 1993: A late phase Ii comparative study of idarubicin + cytarabine and daunorubicin + cytarabine in adult patients with acute non-lymphocytic leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(13): 1995-2005
Abrams, R.A.; Hanson, G.; Hansen, R.M.; Anderson, T. 1986: Phase Ii study of combination chemotherapy with etoposide and amsacrine in relapsed adult leukemia Cancer Treatment Reports 70(4): 535
Martino, R.; Guardia, R.; Altés, A.; Sureda, A.; Brunet, S.; Sierra, J. 1999: Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol Haematologica 84(3): 226-230
Schrecker, A.W.; Smith, R.G.; Gallo, R.C. 1974: Comparative inhibition of purified DNA polymerases from murine leukemia virus and human lymphocytes by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate Cancer Research 34(2): 286-292
Kantarjian, H.M.; Smith, T.; Estey, E.; Polyzos, A.; O'brien, S.; Pierce, S.; Beran, M.; Feldman, E.; Keating, M.J. 1992: Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia American Journal of Medicine 93(6): 599-604
Asou, N.; Adachi, K.; Tamura, J.; Kanamaru, A.; Kageyama, S.; Hiraoka, A.; Omoto, E.; Akiyama, H.; Ohno, R. 2000: Treatment of acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy--multicenter trial of the Japan Adult Leukemia Study Group (JALSG) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(8): 1168-1173
Gunz, F.W.; Vincent, P.C.; Levi, J.A. 1972: Progresses in the therapy of acute leukemia in the adult La Clinica Terapeutica 60(5): 401-414